A Phase 2 interventional study of fish oil in Fish Oils, sponsored by Shanghai Eye Disease Prevention and Treatment Center. Completed at 1 site in China. Open to participants aged 6 Years to 9 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-03-14.
Sponsored by Shanghai Eye Disease Prevention and Treatment Center · Phase 2, Interventional, and Prevention
The goal of this clinical trial is to test the effect of fish oil supplement in terms of vision in children and adolescents. The main question it aims to answer is:
the differences in changes of choroidal thickness, choroidal blood flow, axial length, and visual acuity between the intervention group and the control group Participants will take the fish oil supplement. a baseline examination will be conducted, followed by follow-up visits at 15, 30, and 90 days after the start of the intervention.
Shanghai Eye Disease Prevention and Treatment Center is the lead sponsor of 64 studies on the registry; 30 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
No intervention measures are applied
Twice a day, with one dose of DHA 300mg: EPA 60mg, for a continuous intervention of 90 days
Dietary Supplement: fish oil
Twice a day, with one dose of DHA 300mg: EPA 60mg, for a continuous intervention of 90 days
Axial length
the change of axial length
Time frame: 15±2 days, 30±2 days, and 90±2 days
change in equivalent spherical
change in equivalent spherical in both eyes
Time frame: 15±2 days, 30±2 days, and 90±2 days
This study is completed, as verified in Jul 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Shanghai Eye Disease Prevention and Treatment Center